Infectious Diseases
Pan-Uper-Respiratory Virus Protein Microarray

Acute respiratory diseases (ARDs) account for a significant portion of all acute morbidity and mortality globally, with acute viral respiratory infections being the primary cause (approximately 80%). The Pan-Uper-Respiratory Virus Protein Microarray (PUVP Microarray ) targets cover virtually all respiratory viruses. Additionally, it includes a detection indicator for Mycoplasma, totaling 51 high-quality purified human protein probes. Each protein is independently expressed, purified, and subjected to quality control, ensuring high reliability.

Technical Principle 


Detection Targets

Technical Advantages

  • High Throughput
    Over 100 samples per day
    High Sensitivity
    Detection limit as low as Pg/ML
  • Low Sample Volume
    Requires as little as 1 microliter of sample
    High Repeatability
    Both intra-assay and inter-assay reproducibility of test results are above 0.99

Application Areas

  • Large-scale Epidemiological Surveys
  • Large-scale Epidemiological Surveys
  • Exploration of Clinical Therapeutic Efficacy
  • Large-scale Epidemiological Surveys

Application Examples

  • Negative Control
  • Unvaccinated
  • Related Research Papers

    • [1]Tan Q, Dai L, Wang Y, et al. Anti-pd1/pdl1 igg subclass distribution in ten cancer types and anti-pd1 igg4 as biomarker for the long time survival in nsclc with anti-pd1 therapy[J]. Cancer Immunology, Immunotherapy, 2022, 71(7): 1681‒1691. DOI:10.1007/s00262-021-03106-z. More
    • [2]Tan Q, Wang D, Yang J, et al. Autoantibody profiling identifies predictive biomarkers of response to anti-pd1 therapy in cancer patients[J]. Theranos tics, 2020, 10(14): 6399‒6410. DOI:10.7150/thno.45816. More